ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,985Medicare Part D Prescriptions Filled, Including Refills

Rank: 35 out of 1006

$817K Total Retail Price of All Prescriptions

Rank: 76 out of 1006

319 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

22% of this provider’s 319 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

7% of this provider’s 319 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

2% of this provider’s 13,944 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

47 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
FUROSEMIDE 701 689 1 6
METOPROLOL TARTRATE 638 637 2 7
SIMVASTATIN 534 503 3 1
WARFARIN SODIUM 451 451 4 8
LEVOTHYROXINE SODIUM 409 380 5 2
LISINOPRIL 377 368 6 3
TRAZODONE HCL 355 332 7 21
OMEPRAZOLE 349 342 8 9
AMLODIPINE BESYLATE 341 336 9 4
SERTRALINE HCL 304 256 10 19
ESCITALOPRAM OXALATE 288 280 11 27
DONEPEZIL HCL 285 285 12 17
METOPROLOL SUCCINATE 282 279 13 12
GABAPENTIN 262 239 14 20
RISPERIDONE 260 215 15 40
POTASSIUM CHLORIDE 222 222 16 30
MIRTAZAPINE 220 210 17 26
ATORVASTATIN CALCIUM 208 195 18 5
PANTOPRAZOLE SODIUM 184 172 19 32
DIVALPROEX SODIUM 179 123 20 53
PREDNISONE 161 161 21 33
ALBUTEROL SULFATE 142 140 22 155
OLANZAPINE 140 140 23 68
CITALOPRAM HBR 139 127 24 24
TAMSULOSIN HCL 138 128 25 23
NAMENDA 135 135 26 34
ATENOLOL 129 128 27 13
GLIPIZIDE 122 112 28 69
ALENDRONATE SODIUM 119 118 29 29
LANTUS 111 108 30 43
QUETIAPINE FUMARATE 109 109 31 45
NOVOLOG 108 79 32 94
LEVETIRACETAM 108 90 32 72
NYSTATIN-TRIAMCINOLONE 107 102 34 277
METFORMIN HCL 106 105 35 10
SPIRIVA 105 101 36 48
HYDROCHLOROTHIAZIDE 103 89 37 11
DIGOXIN 97 97 38 52
ZETIA 96 96 39 51
PROAIR HFA 95 74 40 64
CLOPIDOGREL 94 92 41 46
BENZTROPINE MESYLATE 93 71 R 42 106
DIOVAN 93 93 42 16
ADVAIR DISKUS 87 83 44 37
OXYBUTYNIN CHLORIDE ER 75 75 45 92
HYDROMORPHONE HCL 74 55 S2 46 153
SULFAMETHOXAZOLE-TRIMETHOPRIM 74 73 46 118
NOVOLOG FLEXPEN 73 73 48 190
LEXAPRO 73 73 48 103
PRAVASTATIN SODIUM 71 71 50 15
CARBIDOPA-LEVODOPA 71 66 50 80
TRAMADOL HCL 69 68 52 35
FENTANYL 68 60 S2 53 74
PAROXETINE HCL 67 55 54 62
LIDODERM 67 67 54 66
TRAVATAN Z 65 54 56 131
PLAVIX 65 64 56 61
PEN NEEDLE 65 59 56 128
ACETAMINOPHEN-CODEINE 63 63 S3 59 139
ENALAPRIL MALEATE 62 62 60 83
HUMALOG 61 36 61 116
ALLOPURINOL 60 60 62 31
KLOR-CON M20 60 49 62 70
LAMOTRIGINE 60 47 62 119
HALOPERIDOL 59 40 65 129
IPRATROPIUM-ALBUTEROL 59 58 65 73
LEVEMIR FLEXPEN 57 56 67 173
ABILIFY 57 43 67 102
CYMBALTA 57 44 67 41
CRESTOR 56 46 70 18
COLCRYS 56 56 70 186
SEROQUEL 54 54 72 97
FAMOTIDINE 54 50 72 110
VANCOMYCIN HCL 52 52 74 231
AMIODARONE HCL 51 51 75 168
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 6, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.